FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2069526121> ?p ?o ?g. }

• W2069526121 endingPage "769" @default.
• W2069526121 startingPage "759" @default.
• W2069526121 abstract "Background This study (VERxVE) compared the efficacy and safety of the new nevirapine extended-release (NVP XR) formulation dosed once daily with NVP immediate release (IR) twice daily in treatment-naive patients. Methods Randomized, double-blind, double-dummy, parallel group study of HIV-1-infected adult patients with baseline viral load (VL) ≥1,000 copies/ml and CD4 + T-cell count of >50-<400 (males) and >50-<250 cells/mm 3 (females). Patients stratified by baseline VL (≤100,000/>100,000 copies/ml) were randomized 1:1 to NVP XR 400 mg once daily (plus placebo) or NVP IR 200 mg twice daily (plus placebo), both combined with tenofovir disoproxil fumarate (TDF) 300 mg and emtricitabine 200 mg once daily. Primary endpoint was sustained virological response (<50 copies/ml) through week 48 using the time to loss of virological response algorithm. Non-inferiority of NVP XR to NVP IR was tested using Cochran's statistic incorporating baseline VL stratum with pre- specified, non-inferiority margin of -10%. Results Among 1,011 patients randomized and treated, virological response at week 48 was 81.0% (409/505) for NVP XR and 75.9% (384/506) for NVP IR with adjusted difference of 4.9% in favour of NVP XR (95% CI -0.1– 10.0%), demonstrating non-inferiority of NVP XR to NVP IR. This finding was supported by secondary endpoints. The safety profile of NVP XR was similar to NVP IR, but showed numerically fewer treatment-related adverse events. Conclusions NVP XR in combination with TDF and emtricitabine was shown to be non-inferior in efficacy to NVP IR with a similar safety and adverse event pro-file, with the potential for the added convenience of once-daily dosing. Trial registration: ClinicalTrials (NCT): NCT00561925." @default.
• W2069526121 created "2016-06-24" @default.
• W2069526121 creator A5001854525 @default.
• W2069526121 creator A5009282742 @default.
• W2069526121 creator A5012384912 @default.
• W2069526121 creator A5020321074 @default.
• W2069526121 creator A5023109452 @default.
• W2069526121 creator A5026106874 @default.
• W2069526121 creator A5026411408 @default.
• W2069526121 creator A5041319608 @default.
• W2069526121 creator A5046591341 @default.
• W2069526121 creator A5061097917 @default.
• W2069526121 creator A5073460580 @default.
• W2069526121 creator A5076699095 @default.
• W2069526121 creator A5078642431 @default.
• W2069526121 creator A5091239351 @default.
• W2069526121 date "2010-07-01" @default.
• W2069526121 modified "2023-09-24" @default.
• W2069526121 title "Efficacy and Safety of Nevirapine Extended-Release Once Daily versus Nevirapine Immediate-Release Twice-Daily in Treatment-Naive HIV-1-Infected Patients" @default.
• W2069526121 cites W1539792978 @default.
• W2069526121 cites W1963569082 @default.
• W2069526121 cites W1975596284 @default.
• W2069526121 cites W1982011789 @default.
• W2069526121 cites W1996747410 @default.
• W2069526121 cites W2043298036 @default.
• W2069526121 cites W2056118379 @default.
• W2069526121 cites W2056686421 @default.
• W2069526121 cites W2064742811 @default.
• W2069526121 cites W2084180691 @default.
• W2069526121 cites W2094360047 @default.
• W2069526121 cites W2114793603 @default.
• W2069526121 cites W2117261241 @default.
• W2069526121 cites W2123087672 @default.
• W2069526121 cites W2141776019 @default.
• W2069526121 cites W2166306740 @default.
• W2069526121 cites W2170988154 @default.
• W2069526121 cites W2330813625 @default.
• W2069526121 cites W4240153861 @default.
• W2069526121 doi "https://doi.org/10.3851/imp1803" @default.
• W2069526121 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21817198" @default.
• W2069526121 hasPublicationYear "2010" @default.
• W2069526121 type Work @default.
• W2069526121 sameAs 2069526121 @default.
• W2069526121 citedByCount "57" @default.
• W2069526121 countsByYear W20695261212012 @default.
• W2069526121 countsByYear W20695261212013 @default.
• W2069526121 countsByYear W20695261212014 @default.
• W2069526121 countsByYear W20695261212015 @default.
• W2069526121 countsByYear W20695261212016 @default.
• W2069526121 countsByYear W20695261212017 @default.
• W2069526121 countsByYear W20695261212019 @default.
• W2069526121 countsByYear W20695261212020 @default.
• W2069526121 crossrefType "journal-article" @default.
• W2069526121 hasAuthorship W2069526121A5001854525 @default.
• W2069526121 hasAuthorship W2069526121A5009282742 @default.
• W2069526121 hasAuthorship W2069526121A5012384912 @default.
• W2069526121 hasAuthorship W2069526121A5020321074 @default.
• W2069526121 hasAuthorship W2069526121A5023109452 @default.
• W2069526121 hasAuthorship W2069526121A5026106874 @default.
• W2069526121 hasAuthorship W2069526121A5026411408 @default.
• W2069526121 hasAuthorship W2069526121A5041319608 @default.
• W2069526121 hasAuthorship W2069526121A5046591341 @default.
• W2069526121 hasAuthorship W2069526121A5061097917 @default.
• W2069526121 hasAuthorship W2069526121A5073460580 @default.
• W2069526121 hasAuthorship W2069526121A5076699095 @default.
• W2069526121 hasAuthorship W2069526121A5078642431 @default.
• W2069526121 hasAuthorship W2069526121A5091239351 @default.
• W2069526121 hasBestOaLocation W20695261211 @default.
• W2069526121 hasConcept C126322002 @default.
• W2069526121 hasConcept C142462285 @default.
• W2069526121 hasConcept C142724271 @default.
• W2069526121 hasConcept C168563851 @default.
• W2069526121 hasConcept C197934379 @default.
• W2069526121 hasConcept C203014093 @default.
• W2069526121 hasConcept C203092338 @default.
• W2069526121 hasConcept C204787440 @default.
• W2069526121 hasConcept C27081682 @default.
• W2069526121 hasConcept C2779130552 @default.
• W2069526121 hasConcept C2779778239 @default.
• W2069526121 hasConcept C2993143319 @default.
• W2069526121 hasConcept C3013748606 @default.
• W2069526121 hasConcept C71924100 @default.
• W2069526121 hasConcept C90924648 @default.
• W2069526121 hasConceptScore W2069526121C126322002 @default.
• W2069526121 hasConceptScore W2069526121C142462285 @default.
• W2069526121 hasConceptScore W2069526121C142724271 @default.
• W2069526121 hasConceptScore W2069526121C168563851 @default.
• W2069526121 hasConceptScore W2069526121C197934379 @default.
• W2069526121 hasConceptScore W2069526121C203014093 @default.
• W2069526121 hasConceptScore W2069526121C203092338 @default.
• W2069526121 hasConceptScore W2069526121C204787440 @default.
• W2069526121 hasConceptScore W2069526121C27081682 @default.
• W2069526121 hasConceptScore W2069526121C2779130552 @default.
• W2069526121 hasConceptScore W2069526121C2779778239 @default.
• W2069526121 hasConceptScore W2069526121C2993143319 @default.
• W2069526121 hasConceptScore W2069526121C3013748606 @default.
• W2069526121 hasConceptScore W2069526121C71924100 @default.
• W2069526121 hasConceptScore W2069526121C90924648 @default.

• next